Clinicopathological Features of Patients with Malignant Mesothelioma in a Multicenter, Case-Control Study: No Role for ABO-Rh Blood Groups |
Utkan, Gungor
(Department of Medical Oncology, Ankara University School of Medicine)
Urun, Yuksel (Department of Medical Oncology, Ankara University School of Medicine) Cangir, Ayten Kayi (Department of Thoracic Surgery, Ankara University School of Medicine) Kilic, Dalokay (Department of Thoracic Surgery, Baskent University School of Medicine) Ozdemir, Nuriye Yildirim (Medical Oncology Clinic, Ankara Numune Research and Educational Hospital) Oztuna, Derya Gokmen (Department of Biostatistics, Ankara University School of Medicine) Bulut, Erhan (Department of Thoracic Surgery, Ankara University School of Medicine) Arslan, Ulku Yalcintas (Dr. Abdurrahman Yurtaslan Oncology Education and Research Hospital, Medical Oncology Clinic) Kocer, Murat (Department of Medical Oncology, Suleyman Demirel University School of Medicine) Kavukcu, Sevket (Department of Thoracic Surgery, Ankara University School of Medicine) Icli, Fikri (Department of Medical Oncology, Ankara University School of Medicine) |
1 | Urun Y, Ozdemir NY, Utkan G, et al (2012). ABO and Rh Blood Groups and Risk of Colorectal Adenocarcinoma. Asian Pac J Cancer Prev, 13, 6097-100. DOI ScienceOn |
2 | van der Bij S, Schaake E, Koffijberg H, et al (2011). Markers for the non-invasive diagnosis of mesothelioma: a systematic review. Br J Cancer, 104, 1325-33. DOI ScienceOn |
3 | van Meerbeeck JP, Scherpereel A, Surmont VF, Baas P (2011). Malignant pleural mesothelioma: the standard of care and challenges for future management. Crit Rev Oncol Hematol, 78, 92-111. DOI ScienceOn |
4 | Vogelzang NJ, Rusthoven JJ, Symanowski J, et al (2003). Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol, 21, 2636-44. DOI ScienceOn |
5 | Wolpin BM, Chan AT, Hartge P, et al (2009). ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst, 101, 424-31. DOI ScienceOn |
6 | Kao SC, Reid G, van Zandwijk N, Henderson DW, Klebe S (2011). Molecular biomarkers in malignant mesothelioma: state of the art. Pathology, 43, 201-12. DOI ScienceOn |
7 | Kaplan EL, Meier P (1958). Nonparametric estimation from incomplete observations. J Am Statistical Assoc, 53, 457-81. DOI ScienceOn |
8 | Khalili H, Wolpin BM, Huang ES, et al (2011). ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 20, 1017-20. DOI ScienceOn |
9 | Lee KH, Yoon HS, Choi SJ, Kang D (2009). Asbestos exposure and malignant mesothelioma in Korea. Asian Pac J Cancer Prev, 10, 707-10. |
10 | Metintas S, Metintas M, Ucgun I, Oner U (2002). Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest, 122, 2224-9. DOI ScienceOn |
11 | Nakao M, Matsuo K, Hosono S, et al (2011). ABO blood group alleles and the risk of pancreatic cancer in a Japanese population. Cancer Sci, 102, 1076-80. DOI ScienceOn |
12 | Noguchi M, Nakajima T, Hirohashi S, Akiba T, Shimosato Y (1989). Immunohistochemical distinction of malignant mesothelioma from pulmonary adenocarcinoma with antisurfactant apoprotein, anti-Lewisa, and anti-Tn antibodies. Hum Pathol, 20, 53-7. DOI ScienceOn |
13 | Peto R, Pike MC, Armitage P, et al (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer, 35, 1-39. DOI ScienceOn |
14 | Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M (2001). Genetic-susceptibility factor and malignant mesothelioma in the cappadocian region of Turkey. Lancet, 357, 444-5. DOI ScienceOn |
15 | Rusch VW, Giroux D, Kennedy C, et al (2012). Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol, 7, 1631-9. DOI |
16 | Stahel RA, Weder W, Lievens Y, et al (2010). Malignant pleural mesothelioma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21, 126-8. DOI ScienceOn |
17 | Tanrikulu AC, Abakay A, Kaplan MA, et al (2010). A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma. Respiration, 80, 480-7. DOI ScienceOn |
18 | Tischoff I, Neid M, Neumann V, Tannapfel A (2011). Pathohistological diagnosis and differential diagnosis. Recent Results Cancer Res, 189, 57-78. DOI ScienceOn |
19 | Treasure T, Lang-Lazdunski L, Waller D, et al (2011). Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol, 12, 763-72. DOI ScienceOn |
20 | Tsao AS, Wistuba I, Roth JA, Kindler HL (2009). Malignant pleural mesothelioma. J Clin Oncol, 27, 2081-90. DOI ScienceOn |
21 | Utkan G, Buyukcelik A, Yalcin B, et al (2006). Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma. Lung Cancer, 53, 367-74. DOI ScienceOn |
22 | Baris YI, Sahin AA, Ozesmi M, et al (1978). An outbreak of pleural mesothelioma and chronic fibrosing pleurisy in the village of Karain/Urgup in Anatolia. Thorax, 33, 181-92. DOI ScienceOn |
23 | Ben Q, Wang K, Yuan Y, Li Z (2011). Pancreatic cancer incidence and outcome in relation to ABO blood groups among Han Chinese patients: a case-control study. Int J Cancer, 128, 1179-86. DOI ScienceOn |
24 | Berman DW, Crump KS (2008). A meta-analysis of asbestosrelated cancer risk that addresses fiber size and mineral type. Crit Rev Toxicol, 38, 49-73. DOI ScienceOn |
25 | Carbone M, Baris YI, Bertino P, et al (2011). Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc Natl Acad Sci USA, 108, 13618-23. DOI ScienceOn |
26 | De Rienzo A, Tor M, Sterman DH, et al (2002). Detection of SV40 DNA sequences in malignant mesothelioma specimens from the United States, but not from Turkey. J Cell Biochem, 84, 455-9. DOI ScienceOn |
27 | Aird I, Bentall HH, Roberts JA (1953). A relationship between cancer of stomach and the ABO blood groups. Br Med J, 1, 799-801. DOI |
28 | Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R (1990). ABO blood groups and cancer of the pancreas. Int J Pancreatol, 6, 81-8. |
29 | Dogan AU, Baris YI, Dogan M, et al (2006). Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res, 66, 5063-8. DOI ScienceOn |
30 | Elkiran ET, Kaplan MA, Sevinc A, et al (2012). Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients. Med Oncol, 29, 3147-54. DOI ScienceOn |
31 | Emri S, Demir A, Dogan M, et al (2002). Lung diseases due to environmental exposures to erionite and asbestos in Turkey. Toxicol Lett, 127, 251-7. DOI ScienceOn |
32 | Engin H, Bilir C, Ustun H, Gokmen A (2012). ABO blood group and risk of pancreatic cancer in a Turkish population in Western Blacksea region. Asian Pac J Cancer Prev, 13, 131-3. DOI ScienceOn |
33 | Greer JB, Yazer MH, Raval JS, et al (2010). Significant association between ABO blood group and pancreatic cancer. World J Gastroenterol, 16, 5588-91. DOI ScienceOn |
34 | Heintz NH, Janssen-Heininger YM, Mossman BT (2010). Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol, 42, 133-9. DOI ScienceOn |
35 | Hosoi E (2008). Biological and clinical aspects of ABO blood group system. J Med Invest, 55, 174-82. DOI ScienceOn |
36 | Husain AN, Colby TV, Ordonez NG, et al (2009). Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med, 133, 1317-31. |
37 | Iodice S, Maisonneuve P, Botteri E, Sandri MT, Lowenfels AB (2010). ABO blood group and cancer. Eur J Cancer, 46, 3345-50. DOI ScienceOn |
38 | Jordon D, Jagirdar J, Kaneko M (1989). Blood group antigens, Lewisx and Lewisy in the diagnostic discrimination of malignant mesothelioma versus adenocarcinoma. Am J Pathol, 135, 931-7. |